(Q34550164)

3 August 2017

1 reference

title

Rotavirus vaccines: current prospects and future challenges (English)

1 reference

3 August 2017

1 reference

6

Marc-Alain Widdowson

0 references

Thea K. Fischer

object named as

Thea K Fischer

5

0 references

Umesh Parashar

2

object named as

Umesh D Parashar

1 reference

3 August 2017

1

Roger I Glass

1 reference

3 August 2017

3

Joseph S Bresee

1 reference

3 August 2017

Reina Turcios

4

1 reference

3 August 2017

Baoming Jiang

7

1 reference

3 August 2017

Jon R Gentsch

8

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

3 August 2017

1 reference

3 August 2017

volume

368

1 reference

3 August 2017

issue

9532

1 reference

3 August 2017

page(s)

323-332

1 reference

Where and why are 10 million children dying every year?

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

First report from the Asian Rotavirus Surveillance Network

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Global Illness and Deaths Caused by Rotavirus Disease in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Rotavirus and severe childhood diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Rotavirus vaccines: targeting the developing world

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Epidemiology of rotavirus in India

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

The Pathology of Rotavirus-Associated Deaths, Using New Molecular Diagnostics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Histologic distribution of fatal rotaviral infection: an immunohistochemical and reverse transcriptase in situ polymerase chain reaction analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Fatal rotavirus gastroenteritis: an analysis of 21 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Rotavirus antigenaemia and viraemia: a common event?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Rotavirus antigenemia in patients with acute gastroenteritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Extraintestinal rotavirus infections in children with immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Rotavirus and central nervous system symptoms: cause or contaminant? Case reports and review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Detection of rotavirus RNA in cerebrospinal fluid in a case of rotavirus gastroenteritis with febrile seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

High prevalence of rotavirus infection among neonates born at hospitals in Delhi, India: predisposition of newborns for infection with unusual rotavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Neonatal rotavirus infection in Bangladesh: strain characterization and risk factors for nosocomial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

The expanding diversity of rotaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Rotavirus Epidemiology and Surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

The relative frequencies of G serotypes of rotaviruses recovered from hospitalized children with diarrhea: A 10-year survey (1987-1996) in Japan with a review of globally collected data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Molecular epidemiology of human group A rotavirus infections in the United Kingdom between 1995 and 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Unusual diversity of human rotavirus G and P genotypes in India.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Epidemiological profile of rotaviral infection in India: challenges for the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Rotavirus infection in infants as protection against subsequent infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

The role of serum antibodies in the protection against rotavirus disease: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Serum IgG mediates mucosal immunity against rotavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Intussusception, rotavirus, and oral vaccines: summary of a workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York state.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Reappraisal of the Association of Intussusception with the Licensed Live Rotavirus Vaccine Challenges Initial Conclusions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Intussusception among infants given an oral rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

More on RotaShield and intussusception: the role of age at the time of vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Trends in intussusception-associated hospitalizations and deaths among US infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Characterization of the G serotype and genogroup of New Delhi newborn rotavirus strain 116E

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Development of candidate rotavirus vaccines derived from neonatal strains in India

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Possible role of neonatal infection with the asymptomatic reassortant rotavirus (RV) strain I321 in the decrease in hospital admissions for RV diarrhea, Bangalore, India, 1988-1999

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Phase 1 trial of a candidate rotavirus vaccine (RV3) derived from a human neonate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Early phase II trial of human rotavirus vaccine candidate RV3

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Protection against rotavirus infections by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Induction of virus-specific antibody production by lamina propria lymphocytes following intramuscular inoculation with rotavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Rotavirus vaccine administered parenterally induces protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Safety, Immunogenicity, and Protective Efficacy of One and Three Doses of the Tetravalent Rhesus Rotavirus Vaccine in Infants in Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Commentary: Reanalysis of the results of two rotavirus vaccine trials: an appraisal of the reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Introducing new vaccines into developing countries: obstacles, opportunities and complexities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Anticipating rotavirus vaccines: epidemiology and surveillance of rotavirus in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

A human vaccine strain of lamb rotavirus (Chinese) NSP4 gene: complete nucleotide sequence and phylogenetic analyses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968815-6

7 January 2021

10.1016/S0140-6736(06)68815-6

Identifiers

DOI

1 reference

3 August 2017

1 reference